Investor Presentaiton
Some figures at transition OBS (cont'd)
Sampo Group
Storebrand
Level of SHE
No quantitative disclosure
Reduction by 20%
Level of CSM
€0.4b (Mandatum)
No quantitative disclosure
CSM release duration
~7%-8% per annum
(Mandatum)
No quantitative disclosure
No material change in net
profit; no quantitative
disclosure
No quantitative disclosure
No quantitative disclosure
Risk adjustment
Expected operating profit
Expected revenue
ROE
Financial leverage ratio
Limited changes in P &C
insurance revenue; no
quantitative disclosure
No quantitative disclosure
<30% (vs. 26% at 9M 2022)
No quantitative disclosure
Sun Life
Decrease of 15%-20%
~Two-thirds of the transfer
from shareholders' equity is
related to establishing the
CSM
No quantitative disclosure
No quantitative disclosure
Mid-single-digit reduction to
underlying net income in
2022 comparative year
No quantitative disclosure
No quantitative disclosure
No quantitative disclosure
No quantitative disclosure
> 18%
No quantitative disclosure
Talanx
€8.5b (vs. €10.8b) 1
-€9b
No quantitative disclosure
~€4b
~€1,25b
> €38b (2022 estimate)
> 10% (vs. ~9%)
-22%
Zurich
€27b (vs. €28b) at HY22
€9b net of tax at HY 22
No quantitative disclosure
€2.5b net of tax at HY22
Limited impact; no
quantitative disclosure
Limited impact; no
quantitative disclosure
>20% (vs. >14%)
26% at HY22
1 31 December 2022 estimate: >9b (vs <8b)
22
Market updates on impact of IFRS 17 and IFRS 9
EYView entire presentation